JYHZ2300033 | 糠酸氟替卡松维兰特罗吸入粉雾剂(Ⅱ) | fluticasone furoate;vilanterol | Powder for inhalation | Chemical Drugs(5.1) | License Renew | 2023-01-18 | | | | | view |
JYHB2101625 | 糠酸氟替卡松维兰特罗吸入粉雾剂(Ⅱ) | fluticasone furoate;vilanterol | Powder for inhalation | Chemical Drugs(5.1) | Supplementary Application | 2021-12-30 | | | | | view |
JXHL1400039 | 糠酸氟替卡松维兰特罗粉雾剂(Ⅱ) | fluticasone furoate;vilanterol | Powder for inhalation | Chemical Drugs | Import Drug Application | 2014-02-13 | Glaxo Group Limited | Glaxo Group Ltd | Certificate Issued | 2016-09-26 | view |
JXHL1800031 | 糠酸氟替卡松维兰特罗吸入粉雾剂(Ⅱ) | fluticasone furoate;vilanterol | Powder for inhalation | Chemical Drugs(2.4) | Import Drug Application | 2018-02-11 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Certificate Issued | 2018-06-15 | view |
CYHS1800168 | 糠酸氟替卡松维兰特罗吸入粉雾剂(II) | fluticasone furoate;vilanterol | Powder for inhalation | Chemical Drugs(3) | Generic Drug | 2018-07-20 | 正大天晴药业集团股份有限公司 | Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd | In Review | 2018-07-18 | view |
JXHS1600079 | 糠酸氟替卡松维兰特罗吸入粉雾剂(Ⅱ) | fluticasone furoate;vilanterol | Powder for inhalation | Chemical Drugs(5.1) | Import Drug Application | 2017-01-22 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Certificate Issued | 2018-08-07 | view |
JYHB1900018 | 糠酸氟替卡松维兰特罗吸入粉雾剂(Ⅱ) | fluticasone furoate;vilanterol | Powder for inhalation | Chemical Drugs(5.1) | Supplementary Application | 2019-01-09 | | | Filed | 2019-01-11 | view |
JYHB1900923 | 糠酸氟替卡松维兰特罗吸入粉雾剂(Ⅱ) | fluticasone furoate;vilanterol | Powder for inhalation | Chemical Drugs | Supplementary Application | 2019-07-29 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Filed | 2019-08-08 | view |
JYHB2100014 | 糠酸氟替卡松维兰特罗吸入粉雾剂(Ⅱ) | fluticasone furoate;vilanterol | Powder for inhalation | Chemical Drugs(5.1) | Supplementary Application | 2021-01-08 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Certificate Issued | 2021-02-01 | view |
JYHB2100112 | 糠酸氟替卡松维兰特罗吸入粉雾剂(Ⅱ) | fluticasone furoate;vilanterol | Powder for inhalation | Chemical Drugs(5.1) | Supplementary Application | 2021-02-03 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | In Review | 2021-02-03 | view |